HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study
Articolo
Data di Pubblicazione:
2017
Abstract:
Sustained virological response (SVR12) rates at 12 weeks after treatment for HCV-infected patients with decompensated cirrhosis are used when referring to those with moderate functional impairment, while few data are available for those with more severe impairment. The use of the cirrhosis staging system proposed by D'Amico might provide new insights on timing for antiviral therapy.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Antiviral therapy; Direct-acting antivirals; HCV; Hepatitis C; Liver cirrhosis; Aged; Antiviral Agents; Databases; Factual; Drug Therapy; Combination; Female; Hepacivirus; Hepatitis C; Humans; Italy; Liver; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Severity of Illness Index; Sustained Virologic Response
Elenco autori:
Ippolito, Antonio Massimo; Milella, Michele; Messina, Vincenzo; Conti, Fabio; Cozzolongo, Raffaele; Morisco, Filomena; Brancaccio, Giuseppina; Barone, Michele; Santantonio, Teresa; Masetti, Chiara; Tundo, Paolo; Smedile, Antonina; Carretta, Vito; Gatti, Pietro; Termite, Antonio Patrizio; Valvano, Maria Rosa; Bruno, Giuseppe; Fabrizio, Claudia; Andreone, Pietro; Zappimbulso, Marianna; Gaeta, Giovanni Battista; Napoli, Nicola; Fontanella, Luca; Lauletta, Gianfranco; Cuccorese, Giuseppe; Metrangolo, Antonio; Francavilla, Ruggiero; Ciracì, Emanuela; Rizzo, Salvatore; Andriulli, Angelo
Link alla scheda completa:
Pubblicato in: